Added to YB: 2026-10-07
Pitch date: 2026-10-01
086450.KQ [bullish]
DongKook Pharmaceutical Co., Ltd.
+8.33%
current return
Author Info
TrendInvest is a substack for investors who use unconventional data to find opportunities. We go beyond headlines and quarterly reports to spot hidden signals. We track cultural shifts and invest where we think the world is headed. Whether it’s deep-value plays or the hottest retail favorites, we stay flexible. We aim to move quickly and boldly—while keeping a humble, data-driven mindset. Sign up for the newsletter.
Company Info
DongKook Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea and internationally.
Market Cap
KRW 1.0T
Pitch Price
KRW 22.8K
Price Target
32.5K (+32%)
Dividend
N/A
EV/EBITDA
7.97
P/E
13.40
EV/Sales
1.10
Sector
Pharmaceuticals
Category
growth
Dongkook Pharmaceutical: The K-Beauty Platform Hidden Inside a Cheap Pharma Stock with GLP-1 call option for free
086450.KQ: Dongkook is priced as a modest healthcare company at about KRW 19,000 and 10–11x trailing earnings, despite Centellian24’s Madeca Cream surpassing 100M cumulative units and Q2 cosmetics revenue growing 47.6%. A simulated 2028 earnings model supports KRW 32,500 at 12.5x P/E, with GLP-1 optionality largely excluded; the key risk is whether international distribution converts into repeat purchases, pricing power and the assumed margins.
Read full article (9 min)